1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015" provides an overview of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Urticaria Pigmentosa (Mastocytosis, Mastocytoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
C. H. Boehringer Sohn AG and Co. KG 29
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 29
Novartis AG 30
Clinical Trial Overview of Novartis AG 30
AB Science SA 31
Clinical Trial Overview of AB Science SA 31
United Pharmaceuticals SAS 32
Clinical Trial Overview of United Pharmaceuticals SAS 32
Stemline Therapeutics, Inc. 33
Clinical Trial Overview of Stemline Therapeutics, Inc. 33
Premier Research Group Limited 34
Clinical Trial Overview of Premier Research Group Limited 34
Patara Pharma, Inc. 35
Clinical Trial Overview of Patara Pharma, Inc. 35
NicOx S.A. 36
Clinical Trial Overview of NicOx S.A. 36
GlaxoSmithKline Plc 37
Clinical Trial Overview of GlaxoSmithKline Plc 37
Alpha Bioresearch S.L. 38
Clinical Trial Overview of Alpha Bioresearch S.L. 38
Clinical Trial Overview of Top Institutes / Government 39
Centre Hospitalier Regional Universitaire de Besancon 39
Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Besancon 39
Charite - Universitatsmedizin Berlin 40
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 40
Floridsdorf Allergy Center 41
Clinical Trial Overview of Floridsdorf Allergy Center 41
National Taiwan University Hospital 42
Clinical Trial Overview of National Taiwan University Hospital 42
Yuzawa Medical Center 43
Clinical Trial Overview of Yuzawa Medical Center 43
Five Key Clinical Profiles 44
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 65

List of Tables
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 29
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 30
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science SA, 2015* 31
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Pharmaceuticals SAS, 2015* 32
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemline Therapeutics, Inc., 2015* 33
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Premier Research Group Limited, 2015* 34
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Patara Pharma, Inc., 2015* 35
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by NicOx S.A., 2015* 36
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 37
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alpha Bioresearch S.L., 2015* 38
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Besancon, 2015* 39
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 40
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Floridsdorf Allergy Center, 2015* 41
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 42
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuzawa Medical Center, 2015* 43

List of Figures
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 63

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Radiodermatitis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Radiodermatitis Market: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Radiodermatitis, also known as radiation dermatitis, is a significant symptom caused by radiation therapy used in treating cancer as well as exposure to radiation during nuclear disasters. During cance ...

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Eczema - Market Insights, Epidemiology and Market Forecast-2023

Eczema - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Eczema - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.